Back to Research Hub
CG Oncology, Inc. Common stock
CGON
$56.67+2.27 (+4.17%)
CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer.
StreetsValue research for CG Oncology, Inc. Common stock (CGON)
Members get the full report for CG Oncology, Inc. Common stock: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.